$30.00
Nolvadex (generic name: Tamoxifen) is a prescription medication classified as a selective estrogen receptor modulator (SERM). It is primarily used in the treatment and prevention of certain types of hormone receptor–positive breast cancer.
Nolvadex works by blocking estrogen receptors in breast tissue, helping slow or stop the growth of estrogen-dependent cancer cells.
Tamoxifen acts by:
Binding to estrogen receptors
Blocking estrogen stimulation in breast tissue
Reducing recurrence risk in hormone-sensitive cancers
Lowering the risk of invasive breast cancer in high-risk patients
Because estrogen can promote the growth of certain breast cancers, controlling its activity is essential in treatment and prevention strategies.
Used in both early-stage and advanced breast cancer cases.
Prescribed for individuals at elevated risk of developing breast cancer.
Commonly used after surgery, radiation, or chemotherapy to reduce recurrence.
When prescribed appropriately, Nolvadex may:
Reduce the risk of cancer recurrence
Lower the chance of cancer in the opposite breast
Improve long-term survival in hormone receptor–positive cases
Offer an oral treatment option for long-term therapy
Treatment duration often ranges from 5 to 10 years, depending on individual medical evaluation.
Dosage must be determined by a healthcare professional.
Typical Dosage Range:
20–40 mg daily
Taken orally
Duration varies based on diagnosis and treatment plan
Consistency is important, and regular follow-up appointments are required to monitor effectiveness and side effects.
While many patients tolerate Nolvadex well, potential side effects include:
Hot flashes
Vaginal discharge or dryness
Mood changes
Irregular menstrual cycles
Increased risk of blood clots
Rare risk of uterine cancer
Patients should seek immediate medical attention if symptoms of blood clots occur (e.g., leg swelling, chest pain, sudden shortness of breath).
Nolvadex may not be suitable for individuals with:
History of blood clots
Certain uterine conditions
Pregnancy or breastfeeding
Known hypersensitivity to tamoxifen
A thorough medical evaluation is required before starting therapy.
As a SERM, Nolvadex differs from aromatase inhibitors and other endocrine therapies. Treatment choice depends on:
Menopausal status
Cancer receptor profile
Medical history
Risk factors
Your oncologist will determine the most appropriate treatment strategy.
No. It is a hormone therapy medication, not chemotherapy.
Treatment commonly lasts 5–10 years depending on medical guidance.
Yes. Nolvadex is a prescription-only medication.
It is approved for long-term therapy when monitored by a healthcare provider.

















